Development of α-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease
- 1 March 2005
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 13 (6) , 2141-2156
- https://doi.org/10.1016/j.bmc.2004.12.053
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The role of ecotin dimerization in protease inhibitionJournal of Molecular Biology, 2001
- Design and synthesis of dipeptidyl α′,β′-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzainBioorganic & Medicinal Chemistry Letters, 1998
- Synthesis and Stereoselective C-C Bond‐forming Reactions of Peptide AldehydesEuropean Journal of Organic Chemistry, 1996
- The Crystal Structure of Cruzain: A Therapeutic Target for Chagas' DiseaseJournal of Molecular Biology, 1995
- AMoRe: an automated package for molecular replacementActa Crystallographica Section A Foundations of Crystallography, 1994
- Inhibitory Effect of di- and Tripeptidyl Aldehydes on Calpains and CathepsinsJournal of Enzyme Inhibition, 1990
- CHAIN — A crystallographic modeling programJournal of Molecular Graphics, 1988
- Potent new inhibitors of human reninNature, 1982
- Synthesis and biological activity of a ketomethylene analog of a tripeptide inhibitor of angiotensin converting enzymeJournal of Medicinal Chemistry, 1980
- Proteolytic Activities in Cell Extracts of Trypanosoma cruzi*The Journal of Protozoology, 1977